0000899243-21-032753.txt : 20210812
0000899243-21-032753.hdr.sgml : 20210812
20210812162048
ACCESSION NUMBER: 0000899243-21-032753
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210810
FILED AS OF DATE: 20210812
DATE AS OF CHANGE: 20210812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stuart Bryan
CENTRAL INDEX KEY: 0001619846
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38978
FILM NUMBER: 211167861
MAIL ADDRESS:
STREET 1: C/O CIVITAS THERAPEUTICS, INC.
STREET 2: 190 EVERETT AVENUE
CITY: CHELSEA
STATE: MA
ZIP: 02150
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc.
CENTRAL INDEX KEY: 0001680581
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474839948
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-651-8851
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-10
0
0001680581
Fulcrum Therapeutics, Inc.
FULC
0001619846
Stuart Bryan
C/O FULCRUM THERAPEUTICS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
1
0
0
See Remarks
Common Stock
2021-08-10
4
M
0
32000
7.84
A
32000
D
Common Stock
2021-08-10
4
S
0
32000
17.50
D
0
D
Common Stock
2021-08-11
4
M
0
28000
7.84
A
28000
D
Common Stock
2021-08-11
4
S
0
28000
23.75
D
0
D
Stock Option (right to buy)
7.84
2021-08-10
4
M
0
32000
0.00
D
2028-12-17
Common Stock
32000
271571
D
Stock Option (right to buy)
7.84
2021-08-11
4
M
0
28000
0.00
D
2028-12-17
Common Stock
28000
243571
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
This option was granted on December 18, 2018 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of December 18, 2018. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.
President & Chief Executive Officer
/s/ Peter Thomson, as attorney-in-fact for Bryan Stuart
2021-08-12